Harsch, I.A., Schahin, S.P., Radespiel-Tröger, M., Weintz, O., Jahreiß, H., Fuchs, F.S., Wiest, G.H., Hahn, E.G., Lohmann, T., and Konturek, P.C., Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome, Am. J. Respir. Crit. Care Med., 2004, vol. 169, pp. 156–162.

Article  PubMed  Google Scholar 

Blechner, M. and Williamson, A.A., Consequences of obstructive sleep apnea in children, Curr. Probl. Pediatr. Adolesc. Health Care, 2016, vol. 46, pp. 19–26.

Article  PubMed  Google Scholar 

Nagal, H., Hamada, T., Uchida, T., Yamagoe, S., and Suzuki, K., Systemic expression of a newly recognized protein, LECT2, in the human body, Pathol. Int., 1998, vol. 48, pp. 882–886.

Article  Google Scholar 

Lu, X.-J., Chen, J., Yu, C.-H., Shi, Y.-H., He, Y.-Q., Zhang, R.-C., Huang, Z.-A., Lv, J.-N., Zhang, S., and Xu, L., LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor, J. Exp. Med., 2013, vol. 210, pp. 5–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ando, K., Kato, H., Kotani, T., Ozaki, M., Arimura, Y., and Yagi, J., Plasma leukocyte cell-derived chemotaxin 2 is associated with the severity of systemic inflammation in patients with sepsis, Microbiol. Immunol., 2012, vol. 56, pp. 708–718.

Article  CAS  PubMed  Google Scholar 

Yoo, H.J., Hwang, S.Y., Choi, J.-H., Lee, H.J., Chung, H.S., Seo, J.-A., Kim, S.G., Kim, N.H., Baik, S.H., and Choi, D.S., Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis, PLoS One, 2017, vol. 12, p. e0174717.

Article  PubMed  PubMed Central  Google Scholar 

Okumura, A., Unoki-Kubota, H., Matsushita, Y., Shiga, T., Moriyoshi, Y., Yamagoe, S., and Kaburagi, Y., Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver, Biosci. Trends, 2013, vol. 7, pp. 276–283.

PubMed  Google Scholar 

Galea, G.L., Lanyon, L.E., and Price, J.S., Sclerostin’s role in bone’s adaptive response to mechanical loading, Bone, 2017, vol. 96, pp. 38–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frysz, M., Gergei, I., Scharnagl, H., Smith, G.D., Zheng, J., Lawlor, D.A., Herrmann, M., Maerz, W., and Tobias, J.H., Circulating sclerostin levels are positively related to coronary artery disease severity and related risk factors, J. Bone Miner. Res., 2022, vol. 37, pp. 273–284.

Article  CAS  PubMed  Google Scholar 

Golledge, J. and Thanigaimani, S., Role of sclerostin in cardiovascular disease, Arterioscler., Thromb., Vasc. Bi-ol., 2022, vol. 42, pp. e187–e202.

CAS  Google Scholar 

De Backer, W., Obstructive sleep apnea/hypopnea syndrome, Panminerva Med., 2013, vol. 55, pp. 191–195.

CAS  PubMed  Google Scholar 

Javaheri, S., Barbe, F., Campos-Rodriguez, F., Dempsey, J.A., Khayat, R., Javaheri, S., Malhotra, A., Martinez-Garcia, M.A., Mehra, R., and Pack, A.I., Sleep apnea: Types, mechanisms, and clinical cardiovascular consequences, J. Am. Coll. Cardiol., 2017, vol. 69, pp. 841–858.

Article  PubMed  PubMed Central  Google Scholar 

Floras, J.S., Sleep apnea and cardiovascular disease: An enigmatic risk factor, Circ. Res., 2018, vol. 122, pp. 1741–1764.

Article  CAS  PubMed  Google Scholar 

Tietjens, J.R., Claman, D., Kezirian, E.J., De Marco, T., Mirzayan, A., Sadroonri, B., Gold-berg, A.N., Long, C., Gerstenfeld, E.P., and Yeghiazarians, Y., Obstructive sleep apnea in cardiovascular disease: A review of the literature and proposed multidisciplinary clinical management strategy, J. Am. Heart Assoc., 2019, vol. 8, p. e010440.

Article  CAS  PubMed  Google Scholar 

Halpern, R., Iqbal, S.U., Kazis, L.E., Macarios, D., and Badamgarav, E., The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: A retrospective claims analysis of female health plan enrollees with osteoporosis, J. Managed Care Pharm., 2011, vol. 17, pp. 25–39.

Article  Google Scholar 

Arnett, T.R., Acidosis, hypoxia and bone, Arch. Biochem. Biophys., 2010, vol. 503, pp. 103–109.

Article  CAS  PubMed  Google Scholar 

Arnett, T.R., Gibbons, D.C., Utting, J.C., Orriss, I.R., Hoebertz, A., Rosendaal, M., and Meghji, S., Hypoxia is a major stimulator of osteoclast formation and bone resorption, J. Cell. Physiol., 2003, vol. 196, pp. 2–8.

Article  CAS  PubMed  Google Scholar 

Chen, Y.-L., Weng, S.-F., Shen, Y.-C., Chou, C.-W., Yang, C.-Y., Wang, J.-J., and Tien, K.-J., Obstructive sleep apnea and risk of osteoporosis: A population-based cohort study in Taiwan, J. Clin. Endocrinol. Metab., 2014, vol. 99, pp. 2441–2447.

Article  CAS  PubMed  Google Scholar 

Dang, M.H., Kato, H., Ueshiba, H., Omori-Miyake, M., Yamagoe, S., Ando, K., Imanishi, K.I., Arimura, Y., Haruta, I., and Kotani, T., Possible role of LECT2 as an intrinsic regulatory factor in SEA-induced toxicity in D-galactosamine-sensitized mice, Clin. Immunol., 2010, vol. 137, pp. 311–321.

Article  CAS  PubMed  Google Scholar 

Hwang, H.-J., Jung, T.W., Hong, H.C., Seo, J.A., Kim, S.G., Kim, N.H., Choi, K.M., Choi, D.S., Baik, S.H., and Yoo, H.J., LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells, Metabolism, 2015, vol. 64, pp. 1175–1182.

Article  CAS  PubMed  Google Scholar 

Okumura, A., Saito, T., Otani, I., Kojima, K., Yamada, Y., Ishida-Okawara, A., Nakazato, K., Asano, M., Kanayama, K., and Iwakura, Y., Suppressive role of leukocyte cell–derived chemotaxin 2 in mouse anti–type II collagen antibody–induced arthritis, Arthritis Rheum., 2008, vol. 58, pp. 413–421.

Article  CAS  PubMed  Google Scholar 

Wang, Q., Xu, F., Chen, J., Xie, Y.-Q., Xu, S.-L., and He, W.-M., Serum leukocyte cell-derived chemotaxin 2 (LECT2) level is associated with osteoporosis, Lab. Med., 2023, vol. 54, pp. 106–111.

Article  CAS  PubMed  Google Scholar 

Kotake, K., Mitsuboshi, S., Omori, Y., Kawakami, Y., and Kawakami, Y., Evaluation of risk of cardiac or cerebrovascular events in romosozumab users focusing on comorbidities: Analysis of the Japanese Adverse Drug Event Report Database, J. Pharm. Technol., 2023, vol. 39, pp. 23–28.

Article  CAS  PubMed  Google Scholar 

Tirandi, A., Arboscello, E., Ministrini, S., Liberale, L., Bonaventura, A., Vecchié, A., Bertolotto, M., Giacobbe, D.R., Castellani, L., and Mirabella, M., Early sclerostin assessment in frail elderly patients with sepsis: Insights on short-and long-term mortality prediction, Inter-n. Emerg. Med., 2023, vol. 18, pp. 1509–1519.

Article  Google Scholar